SUPPLEMENTAL FINANCIAL INFORMATION BY QUARTER (UNAUDITED) (Details) $ / shares in Units, shares in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2019
USD ($)
item
$ / shares
shares
|
Sep. 30, 2019
USD ($)
$ / shares
shares
|
Jun. 30, 2019
USD ($)
$ / shares
shares
|
Mar. 31, 2019
USD ($)
$ / shares
shares
|
Dec. 31, 2018
USD ($)
item
$ / shares
shares
|
Sep. 30, 2018
USD ($)
$ / shares
shares
|
Jun. 30, 2018
USD ($)
$ / shares
shares
|
Mar. 31, 2018
USD ($)
$ / shares
shares
|
Dec. 31, 2019
USD ($)
item
$ / shares
shares
|
Dec. 31, 2018
USD ($)
item
$ / shares
shares
|
Dec. 31, 2017
USD ($)
item
$ / shares
shares
|
|
| Total revenues | $ 1,447,700,000 | $ 1,316,800,000 | $ 1,506,100,000 | $ 1,200,400,000 | $ 1,413,300,000 | $ 1,221,400,000 | $ 1,442,500,000 | $ 1,383,600,000 | $ 5,471,000,000.0 | $ 5,460,800,000 | $ 5,079,200,000 |
| Operating income | 43,400,000 | 20,800,000 | 105,500,000 | (33,700,000) | 87,300,000 | (21,900,000) | 89,700,000 | 109,900,000 | 136,000,000.0 | 265,000,000.0 | 102,000,000.0 |
| Net earnings (loss) | $ (13,500,000) | $ (54,800,000) | $ 49,400,000 | $ (130,200,000) | $ 170,600,000 | $ (100,400,000) | $ 22,200,000 | $ 17,700,000 | $ (149,100,000) | $ 110,100,000 | $ (487,200,000) |
| Basic earnings per share: | |||||||||||
| Basic earnings per share | $ / shares | $ (0.13) | $ (0.53) | $ 0.48 | $ (1.25) | $ 1.65 | $ (0.82) | $ 0.17 | $ 0.14 | $ (1.44) | $ 0.91 | $ (3.80) |
| Diluted earnings per shares: | |||||||||||
| Diluted earnings per share | $ / shares | $ (0.13) | $ (0.53) | $ 0.17 | $ (1.25) | $ 0.43 | $ (0.82) | $ 0.17 | $ 0.14 | $ (1.44) | $ 0.41 | $ (3.80) |
| Other disclosures | |||||||||||
| Basic (in thousands) | shares | 103,850 | 103,850 | 103,845 | 103,783 | 103,514 | 123,126 | 128,039 | 128,046 | 103,832 | 120,621 | 128,246 |
| Diluted (in thousands) | shares | 103,850 | 103,850 | 135,528 | 103,783 | 135,450 | 123,126 | 128,105 | 128,046 | 103,832 | 130,105 | 128,246 |
| Other income related to derivative assets and liabilities | $ (2,800,000) | $ (41,000,000.0) | $ (165,500,000) | ||||||||
| Other expense related to derivative assets and liabilities | $ 9,600,000 | $ 28,400,000 | $ 54,100,000 | $ 1,000,000.0 | |||||||
| Impairment losses | |||||||||||
| Impairment of long-lived assets | $ 13,800,000 | $ 84,300,000 | $ 13,800,000 | 43,600,000 | |||||||
| U.S. | |||||||||||
| Total revenues | 4,023,200,000 | 4,013,200,000 | 3,723,500,000 | ||||||||
| Impairment losses | |||||||||||
| Impairment of long-lived assets | $ 84,300,000 | ||||||||||
| Tangible asset impairment, number of theatres | item | 40 | ||||||||||
| Tangible asset impairment, number of screens | item | 512 | ||||||||||
| International markets | |||||||||||
| Total revenues | $ 1,447,800,000 | $ 1,447,600,000 | $ 1,355,700,000 | ||||||||
| Impairment losses | |||||||||||
| Tangible asset impairment, number of theatres | item | 14 | ||||||||||
| Tangible asset impairment, number of screens | item | 148 | 118 | |||||||||
| Impairment Of LongLived Assets | |||||||||||
| Impairment losses | |||||||||||
| Tangible asset impairment, number of screens | item | 512 | ||||||||||
| Impairment Of LongLived Assets | U.S. | |||||||||||
| Impairment losses | |||||||||||
| Tangible asset impairment, number of theatres | 13 | 13 | 12 | ||||||||
| Tangible asset impairment, number of screens | item | 150 | 150 | 179 | ||||||||
| Impairment Of LongLived Assets | International markets | |||||||||||
| Impairment losses | |||||||||||
| Tangible asset impairment, number of theatres | item | 15 | 14 | 15 | ||||||||
| Tangible asset impairment, number of screens | item | 148 | 118 | |||||||||